Evidence map›Paper›PMID 35815348›Full record

ArticleJournal of thrombosis and haemostasis : JTH2022

Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study.

Joakim K Sejrup, Birgitte G Tøndel, Vania M Morelli, Maja-Lisa Løchen, Inger Njølstad, Ellisiv B Mathiesen, Tom Wilsgaard, John-Bjarne Hansen, Sigrid K Braekkan

Open access · bronzeAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Joakim K SejrupThrombosis Research Center (TREC), Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0001-8872-4107
Birgitte G TøndelThrombosis Research Center (TREC), Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0003-4684-3743
Vania M MorelliThrombosis Research Center (TREC), Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0002-0872-6645
Maja-Lisa LøchenEpidemiology of Chronic Diseases Research Group, Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0002-8532-6573
Inger NjølstadEpidemiology of Chronic Diseases Research Group, Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0002-6391-231X
Ellisiv B MathiesenBrain and Circulation Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0001-8887-6100
Tom WilsgaardEpidemiology of Chronic Diseases Research Group, Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0002-2709-9472
John-Bjarne HansenThrombosis Research Center (TREC), Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0003-4854-3162
Sigrid K BraekkanThrombosis Research Center (TREC), Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0002-9678-9696
University Hospital of North Norway · NOUiT The Arctic University of Norway · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMyocardial infarction (MI) is associated with an increased risk of venous thromboembolism (VTE). Obesity is a recognized risk factor for both MI and VTE. Whether obesity further increases the risk of VTE in MI patients is scarcely investigated.

aimTo study the joint effect of MI and obesity on the risk of VTE.

methodsStudy participants (n = 29 410) were recruited from three surveys of the Tromsø Study (conducted in 1994-1995, 2001, and 2007-2008) and followed up through 2014. All incident MI and VTE cases during follow-up were recorded. Cox regression models with MI as a time-dependent variable were used to estimate hazard ratios (HRs) of VTE (adjusted for age and sex) by combinations of MI exposure and obesity status. Joint effects were assessed by calculating relative excess risk and attributable proportion (AP) due to interaction.

resultsDuring a median of 19.6 years of follow-up, 2090 study participants experienced an MI and 784 experienced a VTE. Among those with MI, 55 developed a subsequent VTE, yielding an overall incidence rate (IR) of VTE of 5.3 per 1000 person-years (95% confidence interval [CI]: 4.1-6.9). In the combined exposure group (MI+/Obesity+), the IR was 11.3 per 1000 person-years, and the adjusted HR indicated a 3-fold increased risk of VTE (HR 3.16, 95% CI: 1.99-4.99) compared to the reference group (MI-/Obesity-). The corresponding AP was 0.46 (95% CI: 0.17-0.74).

conclusionsThe combination of MI and obesity yielded a supra-additive effect on VTE risk of which 46% of the VTE events were attributed to the interaction.

Indexed as

Myocardial InfarctionVenous ThromboembolismHumansIncidenceNorwayObesityRisk Factorsepidemiologymyocardial infarctionobesityrisk factorvenous thromboembolism

Identifiers

PMID35815348
PMCPMC9796784
OpenAlexW4285012790

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.